Hoffmann Katrin, Nagel Alexander Johannes, Tanabe Kazukata, Fuchs Juri, Dehlke Karolin, Ghamarnejad Omid, Lemekhova Anastasia, Mehrabi Arianeb
Department of General, Visceral and Transplant Surgery, Ruprecht Karls University, Im Neuenheimer Feld, 110 69120, Heidelberg, Germany.
BMC Surg. 2020 Feb 12;20(1):31. doi: 10.1186/s12893-019-0664-8.
Post-hepatectomy liver failure contributes significantly to postoperative mortality after liver resection. The prediction of the individual risk for liver failure is challenging. This review aimed to provide an overview of cytokine and growth factor triggered signaling pathways involved in liver regeneration after resection.
MEDLINE and Cochrane databases were searched without language restrictions for articles from the time of inception of the databases till March 2019. All studies with comparative data on the effect of cytokines and growth factors on liver regeneration in animals and humans were included.
Overall 3.353 articles comprising 40 studies involving 1.498 patients and 101 animal studies were identified and met the inclusion criteria. All included trials on humans were retrospective cohort/observational studies. There was substantial heterogeneity across all included studies with respect to the analyzed cytokines and growth factors and the described endpoints.
High-level evidence on serial measurements of growth factors and cytokines in blood samples used to predict liver regeneration after resection is still lacking. To address the heterogeneity of patients and potential markers, high throughput serial analyses may offer a method to predict an individual's regenerative potential in the future.
肝切除术后肝衰竭是肝切除术后死亡的重要原因。预测个体发生肝衰竭的风险具有挑战性。本综述旨在概述肝切除术后参与肝再生的细胞因子和生长因子触发的信号通路。
检索MEDLINE和Cochrane数据库,不限语言,检索从数据库建立至2019年3月的文章。纳入所有关于细胞因子和生长因子对动物和人类肝再生影响的比较数据的研究。
共识别出3353篇文章,包括40项涉及1498例患者的研究和101项动物研究,均符合纳入标准。所有纳入的人体试验均为回顾性队列/观察性研究。在所有纳入研究中,所分析的细胞因子和生长因子以及所描述的终点存在很大异质性。
仍然缺乏关于通过连续检测血样中的生长因子和细胞因子来预测肝切除术后肝再生的高水平证据。为了解决患者和潜在标志物的异质性问题,高通量连续分析可能为未来预测个体的再生潜力提供一种方法。